Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Kiniksa Pharmaceuticals International, plc (KNSA) had Receiveable Turnover of 12.96 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$202.13M |
|
$14.20M |
|
$20.95M |
|
$181.18M |
|
$182.36M |
|
$19.77M |
|
$3.50M |
|
$23.27M |
|
$23.27M |
|
$14.20M |
|
$14.20M |
|
$14.20M |
|
$14.20M |
|
$19.77M |
|
$20.23M |
|
74.20M |
|
78.98M |
|
$0.19 |
|
$0.18 |
|
| Balance Sheet Financials | |
$527.18M |
|
$1.94M |
|
$236.46M |
|
$763.63M |
|
$139.18M |
|
-- |
|
$56.84M |
|
$196.03M |
|
$567.61M |
|
$552.36M |
|
$567.61M |
|
76.29M |
|
| Cash Flow Statement Financials | |
$137.99M |
|
$-188.99M |
|
$33.02M |
|
$183.58M |
|
$165.60M |
|
$-17.98M |
|
$37.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
89.64% |
|
9.78% |
|
9.78% |
|
-- |
|
11.51% |
|
7.02% |
|
$136.42M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.38 |
|
|
Receiveable Turnover |
12.96 |
6.94 |
|
2.50% |
|
2.57% |
|
1.86% |
|
2.50% |
|
$7.44 |
|
$1.73 |
|
$1.75 |
|